A different kind of molecule
Most of the drugs in a pharmacy are small molecules — aspirin, ibuprofen, statins. They are tiny, rigid, made by chemists step by step, and you can swallow them. A biologic is a different animal entirely. Its active ingredient is a large molecule — a protein, an antibody, a piece of nucleic acid — produced by living cells, not in a flask. Where aspirin has a few dozen atoms, a monoclonal antibody has tens of thousands, arranged in a precisely folded three-dimensional shape.
The key idea: the shape is the medicine. A small molecule works because of its chemical formula. A protein works because it is folded into exactly the right structure — a slightly different fold can be inactive, or worse, harmful. That single fact drives almost every formulation decision in this track.
Meet the family
- Therapeutic proteins — insulin, growth hormone, clotting factors. They replace or supplement something the body needs, and their protein formulation must keep them folded.
- Monoclonal antibodies — large Y-shaped proteins that bind one precise target. A monoclonal antibody underlies many modern cancer and autoimmune drugs.
- Vaccines — they teach the immune system to recognise a threat, using a weakened germ, a purified protein, or genetic instructions.
- Nucleic-acid medicines — mRNA and similar molecules that carry instructions for cells to make a protein themselves. The COVID-19 mRNA vaccines made this category famous.
All of them share one problem: they are too big and too delicate to survive the stomach, so almost every biologic is a parenteral — given by injection or infusion. And all of them have limited stability: they degrade by routes a small molecule never would, which is exactly what the next guides explore.